For your patients
A guide to getting started with CAMZYOS™
Helping you get started with the Patient Support Program for CAMZYOS™
Visit these websites for more information:
For your practice
CAMZYOS Product Monograph
Clinical Practice Consensus Statement and Guidelines for the Management of Hypertrophic Cardiomyopathy (HCM)
Crean AM, et al. General Clinical Practice Update: Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient with Hypertrophic Cardiomyopathy. Can J Cardiol 2024;40(9):1503-23.
Ommen SR, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2024;149(23):e1239-e1311.
Clinical studies
EXPLORER-HCM clinical trial: Olivotto I, et al. Lancet 2020;396:759-69.
EXPLORER-HCM patients enrolled in MAVA-LTE long-term extension trial: Garcia-Pavia P, et al. Eur Heart J 2024;45(47):5071-83.
Practice support
CAMZYOS dose card
CAMZYOS risk management tools
Access information and support
Patient Support Program enrolment form
Reimbursement information
Visit these websites for more information: